Announcements Trials
Browse Landscape

Phase

Phase 2 64Phase 1 62Phase 1/2 41Phase 3 5Phase 2/3 4Phase EARLY_PHASE1 2Phase NA 1Phase 4 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2CNS 1

Conditions

Myelodysplastic Syndromes 2Leukemia, Neutrophilic, Chronic 1Leukemia, Myelomonocytic, Chronic 1

Interventions

Azacitidine 2siltuximab 1pembrolizumab 1nilotinib 1ioversol 1interferon gamma-1b 1fludarabine phosphate 1fluarix 1daratumumab 1Whole-Body Irradiation 1Watchful Waiting 1Transplantation 1Stem Cell Transplantation 1Pleurodesis 1Photopheresis 1Pemetrexed 1Observation 1N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1Mycophenolic Acid 1Mesenchymal Stem Cell Transplantation 1Injections 1Influenza Vaccines 1Imatinib Mesylate 1Hyperbaric Oxygenation 1Fluzone High-Dose 1FluLaval 1FluBlok 1Decitabine 1Cyclosporine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Azacitidine × Myeloid × Clear all
NCT04187703 2026-05-18

5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Recruiting
20 enrolled
Myeloid

Myelodysplastic Syndromes

NCT07071155 2026-03-27

M-HArbOr

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase EARLY_PHASE1 Recruiting
18 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Neutrophilic, Chronic, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡